These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35315290)

  • 21. Prospects for COPD treatment.
    Matera MG; Cazzola M; Page C
    Curr Opin Pharmacol; 2021 Feb; 56():74-84. PubMed ID: 33333428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical nanoparticles for next generation drug delivery to the lungs.
    van Rijt SH; Bein T; Meiners S
    Eur Respir J; 2014 Sep; 44(3):765-74. PubMed ID: 24791828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting microRNAs using nanotechnology in pulmonary diseases.
    Dua K; Chellappan DK; Singhvi G; de Jesus Andreoli Pinto T; Gupta G; Hansbro PM
    Panminerva Med; 2018 Dec; 60(4):230-231. PubMed ID: 30563304
    [No Abstract]   [Full Text] [Related]  

  • 24. Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease.
    Séguin RM; Ferrari N
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1505-17. PubMed ID: 19715448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease.
    Nannini LJ; Cates CJ; Lasserson TJ; Poole P
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006829. PubMed ID: 17943918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled corticosteroids in obstructive airway disease.
    Phua GC; Macintyre NR
    Respir Care; 2007 Jul; 52(7):852-8. PubMed ID: 17594729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanotechnology approaches for inhalation treatment of lung diseases.
    Kuzmov A; Minko T
    J Control Release; 2015 Dec; 219():500-518. PubMed ID: 26297206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.
    Gioia SD; Sardo C; Castellani S; Porsio B; Belgiovine G; Carbone A; Giammona G; Cavallaro G; Conese M
    Curr Drug Deliv; 2017; 14(2):253-271. PubMed ID: 27557670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?
    Castiglia D; Battaglia S; Benfante A; Sorino C; Scichilone N
    Drugs Aging; 2016 Jun; 33(6):375-85. PubMed ID: 27138954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta
    Pirina P; Foschino Barbaro MP; Paleari D; Spanevello A
    Respir Med; 2018 Oct; 143():74-81. PubMed ID: 30261996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-acting beta(2)-adrenoceptor agonists for asthma and COPD].
    Rabe KF; Ukena D; Magnussen H
    Med Klin (Munich); 1997 Dec; 92 Suppl 5():44-9. PubMed ID: 19479397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. siRNA delivery to macrophages using aspherical, nanostructured microparticles as delivery system for pulmonary administration.
    Fischer T; Tschernig T; Drews F; Brix K; Meier C; Simon M; Kautenburger R; Schneider M
    Eur J Pharm Biopharm; 2021 Jan; 158():284-293. PubMed ID: 33285246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin use in pulmonary diseases: State of the art and future perspectives.
    Lelli D; Sahebkar A; Johnston TP; Pedone C
    Pharmacol Res; 2017 Jan; 115():133-148. PubMed ID: 27888157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
    Donohue JF; Ohar JA
    Proc Am Thorac Soc; 2004; 1(3):152-60. PubMed ID: 16113428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.
    Mapel DW; Roberts MH
    Drugs; 2014 May; 74(7):737-55. PubMed ID: 24797158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term management of patients with end-stage lung diseases.
    Briganti DF; D'Ovidio F
    Best Pract Res Clin Anaesthesiol; 2017 Jun; 31(2):167-178. PubMed ID: 29110790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiotropium bromide as add-on therapy to inhaled corticosteroids for treating asthma.
    Matsuse H; Yamagishi T; Kodaka N; Miura A; Kurose Y; Nakano C; Oshio T
    Expert Opin Pharmacother; 2015 Jun; 16(9):1403-9. PubMed ID: 26001185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative approaches for the treatment of airway diseases: focus on nanoparticle medicine.
    Ratemi E; Sultana Shaik A; Al Faraj A; Halwani R
    Clin Exp Allergy; 2016 Aug; 46(8):1033-42. PubMed ID: 27404025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.